His NIHSS score at 6.10pm was 11, with points for right sided paralysis, right hemineglect, and visual neglect (versus field cut).
Deltd   Bicep   Tricp   ECR/U   ExDig   FlDig   DorsI   OppPB  Axill   mscut   [**Month/Day (1) 21443**]   [**Name6 (MD) 21443**]   [**Name8 (MD) 21443**]   md/ul   ulnar   medin         C5     C5-6     C7     C6-7     C7      C8      T1 C8-T1       L  5       5       5       5       5       5       5 5       R  ALL 0 -----------'        Ilpso   Addct   Glmed   Glmax   Qufem   Hamst   TibAn [**First Name9 (NamePattern2) 2778**]    [**Last Name (un) 938**]  Femor   obtur   supgl   infgl   femor   [**First Name9 (NamePattern2) 21444**]   [**Last Name (un) 18709**]   tibil dpper        L1-2    L2-3    L4-5    L5-S1   L3-4    L5-S2   L4-5 S1-2 L5       L  5       5       5       5       5       5       5 5  5       R  ALL 0 ------------' When RUE held to face he does say that that is his hand.
He received an injection at 7.5 hours from last known well time, of either thrombolytic (desmoteplase) or placebo after randomization.
He was admitted to the neuro ICU for close post-lytic monitoring of blood pressure and vital signs.
Hba1c was checked for risk stratification and was 7.9.
His primary care physician should consider increasing his diabetes medications for better glycemic control.
Speech was fluent and he was able to read, repeat and write with He was initially kept NPO with tube feeds.
FLP was checked, although he was on maximal statin therapy and showed an elevated LDL.
The patient was startd on adjunct therapy with niacin.
ASA was started 24 hours after the study medication injection and afterward Aggrenox was added at 1 cap po qd x 3 days, followed by [**Hospital1 **] dosing to be taken after discharge.
He was mildly hypertensive on the floor to SBP 160's and patient was started on captopril 6.25 mg tid with good response, in additiion to clonidine patch.
He was seen by physical therapy and occupational therapy and cleared for rehabilitation.
His main issues on d/c:  1)Neuro: -Continue Aggrenox 1 cap po bid for stroke prophylaxis.
3)Endo: -Continue [**Hospital1 **] glyburide and regular insulin coverage.
The patient had FS in 200-300 range prior to leaving and so sliding scale may have to be tightened.
Medications on Admission:  glyburide 5mg QD, hydroxyzine 25mg QD, Fosinopril 40 mg QHS, simvastatin 80 mg QD, proscar 5 mg QHS, clonidine TTS2, 2 patches Q7days, Travatin eye drops one gtts OU QHS   Discharge Medications: 1.
Simvastatin 40 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Clonidine 0.2 mg/24 hr Patch Weekly Sig: Two (2) Patch Weekly Transdermal Q7DAYS ().
Niacin 500 mg Capsule, Sustained Release Sig: One (1) Capsule, Sustained Release PO HS (at bedtime).
Glyburide 5 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Bisacodyl 5 mg Tablet, Delayed Release (E.C.)
Dipyridamole-Aspirin 200-25 mg Cap, Multiphasic Release 12 HR Sig: One (1) Cap PO BID (2 times a day).
Sodium Chloride 0.9 % Parenteral Solution Sig: Three (3) ML Intravenous  DAILY (Daily) as needed: FLUSH for peripheral iv lines.
Latanoprost 0.005 % Drops Sig: One (1) Drop Ophthalmic  HS (at bedtime).
Hydroxyzine HCl 25 mg Tablet Sig: One (1) Tablet PO once a day.
Insulin Regular Human 100 unit/mL Solution Sig: 0-8 units Injection ASDIR (AS DIRECTED): Patient will need finger sticks q6hrs.
Follow regular insulin sliding scale sent with paperwork.
Captopril 12.5 mg Tablet Sig: 0.5 Tablet PO three times a day.
